The role of omega-3 fatty acids from fish in prevention of cardiovascular diseases;Uloga omega-3 masnih kiselina iz riba u prevenciji kardiovaskularnih bolesti

Lijecnicki Vjesnik

Volumn 129, Issue 10-11, 2007, Pages 350-355

  Reiner, Željko ^a   Tedeschi Reiner, Eugenia ^b   Štajminger, Gordana ^c,d  

^a UNIVERSITY OF ZAGREB   (Croatia)

^b Klinika za O ne Bolesti KB Sestre Milosrdnice

^c Clinic for Internal Medicine Dr Gordana tajminger   (Croatia)

^d KBC Zagreb   (Croatia)

Author keywords

Arrhythmia etiology, prevention and control; Cardiovascular diseases prevention and control; Death, sudden, cardiac prevention and control; Fatty acids, omega 3 pharmacology; Myocardial infarction prevention and control, mortality; Therapeutic use, aAdministration and dosage

Indexed keywords

EID: 38049082931     PISSN: 00243477     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (69)

1. Bang HO, Dyeherg J. Plasma lipids and lipoproteins in Greenland westcoast Eskimos. Acta Med Scand 1972; 192:85-94.
2. Kromann N, Green A. Epidemiological studies in the Upernavik district, Greenland. Acta Med Scand 1980;208:401-6.
3. Hirai A, Terano T, Tamura Y, Yoshida S. Eicosapentaenoic acid and adult diseases in Japan: epidemiological and clinical aspects. J Intern Med Suppl 1989:225:69-75.
4. Kromhout D, Bosschieter EB, de Lezenne-Coulander C. The inverse relation between fish consumption and 20-year mortality from coronary heart disease. N Engl J Med 1985;312-1205-9.
5. Daviglus ML, Stamler J, Orencia AJ i sur. Fish consumption and the 30-year risk od fatal myocardial infarction. N Engl J Med 1997;336: 1046-53.
6. Zhang J, Sasaki S, Amano K i sur. Fish consumption and mortality from all causes, ischemic heart disease, and stroke: an ecological study. Prev Med 1999;28:520-9.
7. Hu FB, Bronner L, Willen WC i sur. Fish and omega-3 fatty acid intake and risk of coronary heart disease in women. JAMA 2002;287:1815-21.
8. Burr ML, Fehily AM, Gilbert JF. Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART). Lancet 1989;2:757:61.
9. GISSI-Prevenzione Investigators. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione Trial. Gruppo Italiano per lo Studio della Sopravvivenza nell 'Infarto Miocardico. Lancet 1999;354:447-55.
10. Singh RB, Niaz MA, Sharma JP i sur. Randomized double-blind, placebo-controlled trial od fish oil and mustard oil in patients with suspected acute myocardial infarction: the Indian experiment of infarct survival. Cardiovasc Drugs Ther 1997;11:485-91.
11. Albert CM, Campos H, Stampfer MJ i sur. Blood levels of long-chain n-3 fatty acids and the risk of sudden death. N Engl J Med 2002;346: 1113-8.
12. Yokoyama M. Effects of eicosapentaenoic acid (EPA) on major cardiovascular events in hypercholesterolemic patients: the Japan EPA Lipid Intervention Study (JELIS), Circulation 2005;112:3362-3.
13. Reiner-Tedeschi E, Reiner Ž. Omega-3 masne kiseline u prevenciji kardiovaskularnih bolesti. Medix 2002;43:29-30.
14. Weber P, Raederstorff D. Triglyceride-lowering effect of omega-3 LC-polyunsaturated fatty acids - a review. Nutr Metab Cardiovasc Dis 2000;10:28-37.
15. Lu G, Windsor SL, Harris WS. Omega-3 fatty acids alter lipoprotein subfraction distributions and the in vitro conversion of very low density lipoproteins to low density lipoproteins. J Nutr Biochem 1999;10: 151-8.
16. Haris WS. n-3 fatty acids and the prevention of coronary atherosclerosis. Am J Clin Nutr 2000;71(1 Suppl.):224S-227S.
17. Balk EM; Lichtenstein AH, Chang M, Kupelnich B, Chew P, Lan J. Effects of omega-3 fatty acids on serum marker of cardiovascular disease risk: a systematic review. Atherosclerosis 2006;189:19-30.
18. Harris WS. N-3 fatty acids and serum lipoproteins: human studies. Am J Clin Nutr 1997;65:16455-545.
19. Marcovina SM, Kennedy H, Bittolo Bon G, Cazdato G, Valli C, Casiglia E. Fish intake, independent of apo(a) size, accounts for lower plasma lipoprotein(a) levels in Bantu fishermen of Tanzania: The Lugalawa Study. Arterioscler Thromb Vasc Biol 1999;19:1250-6.
20. Reiner Ž, Salzer B. The effects of omega-3 fatty acids on serum lipoproteins and apoproteins in patients with hyperlipoproteinaemia. Period Biol 1993;95:484.
21. Salzer B, Reiner Ž, Stavljenić A. A hypolipemic effect of ornega-3-fatty acids in type V hyperlipoproteinemia. IX European Congress of Clinical Chemistry. Cracow 1991;137.
22. Durrington PN, Bhatnagar D, Mackness MI i sur. An omega-3 polyunsaturated fatty acid concentrate administered for one year decreased triglycerides in simvastatin treated patients with coronary heart disease and persisting hypertriglyceridaemia. Heart 2001;85:544-8.
23. McKenny JM, Sica D. Role of prescription omega-3 fatty acids in the treatment of hypertriglyceridemia. Pharmacotherapy 2007;27:715-28.
24. Morris MC, Sacks F, Rosner B. Does fish oil lower blood pressure; A meta-analysis of controlled trials. Circulation 1993;88-523-33.
25. Appel LJ, Miller ER 3d, Seidler AJ, Whelton PK. Does supplementation od diet with »fish oil« reduce blood pressure? A meta-analysis of controlled clinical trials. Arch Intern Med 1993;153:1429-38.
26. Lopez D, Orta X. Upregulation of endothelial nitric oxide synthese in rat aorta after ingestion of fish oil-rich diet. Am J Physiol Heart Circ Physiol 2004;287:H567-72.
27. Das UN. Long-chain polyunsaturated fatty acids interact with nitric oxide, superoxide anion, and transforming growth factor-beta to prevent human essential hypertension. Eur J Clin Nutr 2004;58:195-203.
28. Wensing AG, Mensaink RP, Hornstra G. Effects of dietary n-3 polyunsaturated fatty acids from plant and marine origin on platelet aggregation in healthy elderly subjects. Br J Nutr 1999;82:183-191.
29. Mehta J, Laxson D, Saldeen T. Reduction in plasminogen activator inhibitor-1 (PAI-1) with omega-3 polyunsaturated fatty acid (PUFA) intake. Am Heart J 1998;116:1201-6.
30. Calder PC. Dietary modification of inflammation by lipids. Proc Nutr Soc 2002;61:345-58.
31. Mori TA, Beilin LJ. Omega-3 fatty acids and inflammation. Curr Atheroscler Rep 2004;6:461-7.
32. Wallace JMW. Turlev E, Gilmore WS, Strain JJ. Dietary fish oil supplementation alters leukocyte function and cytokine production in healthy women. Arterioscler Thromb Vasc Biol 1995;15:185-9.
33. Bauman KH, Hessel F, Larass I i sur. Dietary ω-3, ω-6. and ω-9 unsaturated fatty acids and growth factor nad cytokine gene expression in unstimulated and stimulated monocytes. Arterioscler Thromb Vasc Biol 1999;19:59-66.
34. Pakala R, Benedict C. Eicosapentaenoic acid and docosahexaenoic acid selectively attenuate U46619-induced smooth muscle cell proliferation. Lipids 1999;34:915-20.
35. Johansen O, Seljeflot I, Hostmark AT, Arnesen H. The effect of supplementation with omega-3 fatty acids on soluble markers of endothelial function in patients with coronary heart disease. Arterioscler Thromb Vasc Biol 1999;19:1681-6.
36. Thies F, Garry JMC, Yaqoob P i sur. Association of n-3 polyunsaturated fatty acids with stability of atherosclerotic plaques: a randomized controlled trial. Lancet 2003;361:477-85.
37. Von Schachy C, Angerer P, Kothny W. The effect od dietary omega-3-fatty acids on coronary atherosclerosis. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 1999;130:554-62.
38. Mita T, Watada H, Ogihara T i sur. Eicosapentaenoic acid reduces the progression of carotid intima-media thickness in patients with type 2 diabetes. Atherosclerosis 2007;191:162-7.
39. Leaf A, Jorgensen MB, Jacobs AK i sur. Do fish oils prevent restenosis after coronary angioplasty? Circulation 1994;90:2248-57.
40. Cairns JA, Gill J, Morton B i sur. Fish oils and low-molecular-weight heparin for the reduction of restenosis after percutaneous transluminar coronary angioplasty. The EMPAR Study. Circulation 1996;90:1553-60.
41. Mozaffarian D, Bryson CL, Lemaitre RN, Burke GL, Siscovick DS. Fish intake and risk of heart failure. J Am Coll Cardiol 2005;45:2015-21.
42. Gudbjarnason S, Hallgrimsson J. The role of myocardial membrane lipids in the development of cardiac necrosis. Acta Med Scand 1976; 587:17-26.
43. Leaf A, Kang JX, Xiao YF, Billmann G. Clinical prevention of sudden cardiac death by n-3 polyunsaturated fatty acids and mechanism of prevention of arrhythmias by n-3 fish oils. Circulation 2003;107:2646-52.
44. Matthau NR, Jordan H, Chung M, Lichtenstein AH, Lathrop DA, Lan J. A systematic review and meta-analysis of the impact of omega-3 fatty acids on selected arrhythmia outcomes in animal models. Metabolism 2005;54:1557-65.
45. Xiao Y-F, Gomez AM, Morgan JP i sur. Suppression of voltage-gated L-type Ca2+ currents by polyunsaturated fatty acids in adult and neonatal rat cardiac myocytes. Proc Natl Acad Sci USA 1997;94:4182-7.
46. Albert CM, Hennkens CH, O'Donnell CJ, Ajani UA, Carey VJ, Willett WC. Fish consumption and risk of sudden cardiac death. JAMA 1998; 279:23-8.
47. Leaf A, Kang JX, Xiao YF, Billmann GE, Voskuyl RA. Experimental studies on antiarrhythmic and antiseizure effects of polyunsaturated fatty acids in excitable tissues. J Nutr Biochem 1999;10:440-8.
48. Honore' E, Barhanin J, Attali B i sur. External blocade of the major cardiac delyed-rectifier K+ channel (Kv 1.5) by polyunsaturated fatty acids. Proc Natl Acad Sci USA 1994;91:1937-44.
49. Boriani G, Valzania C, Diemberger I. Potential of non-antiarrhythmic drugs to provide an innovative upstream approach to the pharmacological prevention of sudden cardiac death. Expert Opin Invest Drug 2007; 16:605-23.
50. Christiansen JH, Gustenhoff P, Koruo E i sur. Effect offish oil on heart rate variability in survivors of myocardial infarction: a double blind randomised controlled trial. Br Med J 1996;312:677-8.
51. Marchioli R, Barzi F, Bomba E i sur. Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analyses of the results of the Gruppo italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI) - Prevenzione. Circulation 2002;105:1897-903.
52. Mozaffarian D, Psaty BM, Rimm EB i sur. Fish intake and risk of incident atrial fibrillation. Circulation 2004;110:368-73.
53. Da Chunha DNQ, Hamlin RL, Billman GE, Carnes CA. N-3 (omega-3) polyunsaturated fatty acids prevent acute atrial electrophysiological remodelling. Br J Pharmacol 2007;150:281-5.
54. Calo L, Bianconi L, Colivicchi F i sur. N-3 fatty acids for the prevention of atrial fibrillation after coronary artery bypass surgery: a randomized, controlled trial. J Am Coll Cardiol 2005;45:1723-8.
55. Mozaffarian D, Geelen A, Brouwer IA, Geleijuse JM, Zock PL, Kafan MR. Effect offish oil on heart rate in humans: a meta-analyses of randomized controlled trials. Circulation 2005;112:1945-52.
56. Tofl I, Bonaa KH, Ingebretsen OC, Nordoy A, Jensen T. Effects of n-3 polyunsaturated fatty acids on glucose homeostasis and blood pressure in essential hypertension. Ann Intern Med 1995;123:911-8.
57. Friedberg CE, Heine RJ, Jansen MJFM, Grobbee DE. Fish oil and glycemic control in diabetes - a meta-analysis. Diabetes Care 1998; 21:494-500.
58. Woodman RJ, Mori TA, Burke V, Puddley IB, Watts GF, Beilin LJ. Effects of purified eicosapentaenoic and docosahexaenoic acids on glycemic control, blood pressure, and serum lipids in type 2 diabetic patients with treated hypertension. Am J Clin Nutr 2002;76:1007-15.
59. Connor WE, Prince MJ, Ullmann D i sur. The hypotriglyceridemic effect of fish oil in adult-onset diabetes without adverse glucose control. Ann NY Acad Sci 1993;683:337-40.
60. Farmer A, Montori V, Dinneen S, Clar C. Fish oil in people with type 2 diabetes mellitus. Cochrane Database Syst Rev 2004;(1):CD003205.
61. Ebbeson SO, Risica PM, Ebbeson LO, Kemish JM, Tejero ME. Omega-3 fatty acids improve glucose tolerance and components of the metabolic syndrome in Alaskan Eskimos: the Alaska Siberria project. Int J Curcumpolar Health 2005;64:396-408.
62. Diep QN, Touyz RM, Schiffrin EL. Docosahexaenoic acid, a peroxisome proliferator-activated receptor-alpha ligand, induces apoptosis in vascular smooth muscle cells by stimulation od p38 mitogen-activated protein kinase. Hypertension 2000;36:851-5.
63. Chambrier C, Bastard JP. Eicosapentaenoic acid induces mRNA expression of peroxisome proliferator-activated receptor gamma. Obes Res 2002;10:518-25.
64. Eritsland J, Arnesen H, Gronseth K, Fjeld NB, Abdelnoor M. Effect of dietary supplementation with n-3 fatty acids on coronary artery bypass graft patency. Am J Cardiol 1996;77:31-6.
65. Kris-Etherton PM, Harris WS, Appel LJ. for the Nutrition Committee. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular Disease. Circulation 2002;106:2747-57.
66. Van de Werf F, Ardissino D, Betriu A i sur. Management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J 2003;24:28-66.
67. Lamotte M, Annemans L, Kawalec P, Zoellner Y. A multi-country health economic evaluation of highly concentrated n-3 polyunsaturated fatty acids in secondary prevention after myocardial infarction. Pharmacoeconomics 2006;24:783-95.
68. Quilici S, McGuire M, Zoellner Y. A cost-effectiveness analysis of n-3 PUFA (Omacor) treatment in post-M patients. Int J Clin Pract 2006;60: 922-32.
69. Brunton S, Collins N. Differentiating prescription omega-3-acid ethyl esters (P-OM3) from dietary-supplement omega-3 fatty acids. Curr Med Res Opin 2007;23:1139-45.